NARA Discovery
Article Details
← Back to Search Results
Journal Article

A multi-dimensional comparative study of 505(b)(2) NDAs approved by FDA and Class 2 NDAs approved by NMPA from 2017 to 2023: Uncovering trends, characteristics, and regulation of modified new drugs

Lixia Fu; Songtao Dong; Ran Xie; Guoshu Jia; Nan Zhao; Qian Xiang; Xiwei Ji; Xia Zhao; Xiaoyuan Chen; Lingyue Ma; Yimin Cui
Regulatory Toxicology and Pharmacology · Vol. 162 · pp. 105864 · 2025
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalRegulatory Toxicology and Pharmacology
PublisherAcademic Press
Publication Date2025-11-01
Publication Year2025
Volume162
Pages105864
Document TypeJournal Article
eISSN0273-2300
DOI10.1016/j.yrtph.2025.105864
SubjectEnvironmental Science

Access Information

NARA Access Coverage1981-06-01~Current
Journal Homepagehttps://www.sciencedirect.com/science/journal/02732300
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.